Brief: Eckert & Ziegler To Supply Nucleus Radiopharma With Therapeutic Radioisotopes Ac-225 And Lu-177

Eckert & Ziegler SE

31/01/2024 13:03

Jan 31 (Reuters) - ECKERT & ZIEGLER STRAHLEN UND
MEDIZINTECHNIK AG  EUZG.DE :
    * TO SUPPLY NUCLEUS RADIOPHARMA WITH THERAPEUTIC
RADIOISOTOPES
AC-225 AND LU-177
    * ECKERT & ZIEGLER - ECKERT & ZIEGLER AND NUCLEUS
RADIOPHARMA
SIGNED EXTENSIVE SUPPLY AGREEMENTS FOR MAJOR THERAPEUTIC
RADIOISOTOPES
    * ECKERT & ZIEGLER - MANUFACTURING OF LARGER QUANTITIES OF
GMP-GRADE AC-225 IS EXPECTED TO START IN 2024
    * ECKERT & ZIEGLER - ECKERT & ZIEGLER WILL SERVE AS CORE
SUPPLIER
FOR HIGH-QUALITY LUTETIUM-177 (LU-177) AS WELL AS ACTINIUM-225
(AC-225), BOTH IN NON-CARRIER-ADDED FORM
    * ECKERT & ZIEGLER - NUCLEUS WILL USE RADIOISOTOPES TO
COMPLEMENT
AND ADVANCE THEIR SERVICES FOR CLINICAL DEVELOPMENT AND
MANUFACTURING OF RADIOPHARMACEUTICALS
    * ECKERT & ZIEGLER - WHILE ECKERT & ZIEGLER HAS SUCCESSFULLY
ESTABLISHED A GMP-COMPLIANT PRODUCTION FOR LU-177 IN 2023 AND IS
STEADILY UPSCALING CAPACITIES, MANUFACTURING OF LARGER
QUANTITIES OF GMP-GRADE AC-225 IS EXPECTED TO START IN 2024.

Source text for Eikon:  ID:nEQ3smwXSa 
Further company coverage:  EUZG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))